{"resourceType":"CodeSystem","id":"ssf-2-cervix-codesystem","text":{"status":"generated","div":"<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This case-sensitive code system <code>https://hapi.fhir.tw/fhir/CodeSystem/ssf-2-cervix-codesystem</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">010<a name=\"ssf-2-cervix-codesystem-010\"> </a></td><td>個案的血清 SCC-Ag 檢驗值陽性/大於正常值</td></tr><tr><td style=\"white-space:nowrap\">020<a name=\"ssf-2-cervix-codesystem-020\"> </a></td><td>個案的血清 SCC-Ag 檢驗值陰性/正常值；正常值以內</td></tr><tr><td style=\"white-space:nowrap\">030<a name=\"ssf-2-cervix-codesystem-030\"> </a></td><td>個案的血清 SCC-Ag 檢驗值為臨界值；不確定陽性或陰性</td></tr><tr><td style=\"white-space:nowrap\">988<a name=\"ssf-2-cervix-codesystem-988\"> </a></td><td>不適用。(1) 子宮頸原位癌 (2) 治療前切片檢查結果非為鱗狀癌或鱗狀腺侵襲癌者 (3) 已於外院開始首次療程且無外院檢驗值</td></tr><tr><td style=\"white-space:nowrap\">999<a name=\"ssf-2-cervix-codesystem-999\"> </a></td><td>(1) 病歷未記載或不詳 (2) 未進行血清 SCC-Ag 檢驗</td></tr></table></div>"},"url":"https://hapi.fhir.tw/fhir/CodeSystem/ssf-2-cervix-codesystem","version":"0.1.0","name":"SSF2cervixCS","title":"SSF2 子宮頸癌-SCC 抗原","status":"draft","experimental":false,"date":"2023-09-26T09:09:58+08:00","publisher":"Kuo","contact":[{"name":"Kuo","telecom":[{"system":"url","value":"http://example.org/example-publisher"}]}],"description":"Serum Squamous Cell Carcinoma Antigen (SCC-Ag) : Lab Value vs. Normal Value Code System","caseSensitive":true,"content":"complete","count":5,"concept":[{"code":"010","display":"個案的血清 SCC-Ag 檢驗值陽性/大於正常值"},{"code":"020","display":"個案的血清 SCC-Ag 檢驗值陰性/正常值；正常值以內"},{"code":"030","display":"個案的血清 SCC-Ag 檢驗值為臨界值；不確定陽性或陰性"},{"code":"988","display":"不適用。(1) 子宮頸原位癌 (2) 治療前切片檢查結果非為鱗狀癌或鱗狀腺侵襲癌者 (3) 已於外院開始首次療程且無外院檢驗值"},{"code":"999","display":"(1) 病歷未記載或不詳 (2) 未進行血清 SCC-Ag 檢驗"}]}